Skip to main content
Celestra Inc. logo

Celestra Inc. — Investor Relations & Filings

Ticker · 352770 ISIN · KR7352770002 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 385 across all filing types
Latest filing 2026-05-18 Regulatory Filings
Country KR South Korea
Listing KO 352770

About Celestra Inc.

https://celestrahealth.com/

Celestra Inc. develops and commercializes digital biomarkers for monitoring neurological conditions. The company's core product is the Celestra Health platform, an FDA-designated Class II medical device that provides quantitative gait analysis for patients in their natural environment. The platform utilizes wearable smart insoles equipped with gyroscopes, accelerometers, and pressure sensors to collect movement data. This data is processed by a cloud-based system using advanced machine learning algorithms to measure over 200 aspects of a patient's gait. The system is designed to detect subtle changes in disease progression for conditions such as Multiple Sclerosis and Parkinson’s Disease earlier than traditional clinical assessments. It offers laboratory-grade accuracy, providing clinicians with actionable insights through a proprietary composite index and enabling pharmaceutical firms to assess drug therapy effectiveness more efficiently.

Recent filings

Filing Released Lang Actions
기타시장안내 (상장적격성 실질심사 대상결정 기한 안내 )
Regulatory Filings Classification · 92% confidence The document is an official stock exchange notice (“기타시장안내”) regarding the deadline for deciding whether the company is subject to a substantive listing eligibility review. It contains no financial statements or report attachments but is a procedural regulatory announcement by the exchange. It therefore falls under “Regulatory Filings” (RNS).
2026-05-18 Korean
주권매매거래정지기간변경 (상장적격성 실질심사 대상(사유발생))
Regulatory Filings Classification · 78% confidence The document is a brief regulatory announcement regarding the change in the stock trading suspension period due to listing eligibility review. It does not present financial data or constitute a report itself, nor does it announce dividends, board changes, or financial results. It is a compliance/regulatory notice by the exchange. Therefore, it falls under the general “Regulatory Filings” category (RNS).
2026-05-15 Korean
기타시장안내 (상장적격성 실질심사 관련)
Regulatory Filings Classification · 82% confidence The document is a Korean exchange announcement (“기타시장안내”) informing that the company’s quarterly revenue fell below KOSDAQ listing requirements, triggering a suitability review under listing regulations. It is a regulatory notice from the exchange, not an actual financial report or full delisting notice. Thus it fits the general “Regulatory Filings” category (RNS).
2026-05-15 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report) for the period January 1, 2026 to March 31, 2026. It contains detailed sections on company overview, business description, product information, and financial asset tables which are substantive interim financial disclosures rather than a short announcement. This matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
반기또는분기매출액미달사실발생
Regulatory Filings Classification · 85% confidence The document is a brief regulatory announcement disclosing that the company’s quarterly revenue fell below a specified threshold (₩30 mln), without providing full financial statements or substantive analysis. It is not an earnings release of comprehensive results or an interim report; rather, it’s a compliance notice under exchange rules. This fits “Regulatory Filings (RNS)” as a fallback for miscellaneous compliance disclosures.
2026-05-15 Korean
[기재정정]회생절차개시결정
Regulatory Filings Classification · 96% confidence The document is a regulatory disclosure under the Korean Capital Markets Act (자본시장법) reporting a correction (“정정신고(보고)”) to a prior announcement of a court decision to commence rehabilitation (bankruptcy) proceedings. It contains no financial statements, earnings information, or investor presentation materials, and it is not a management or governance report. There is no dedicated “correction” or “bankruptcy” category in our taxonomy, so this is best classified as a general regulatory filing.
2026-05-14 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.